PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Repurposed drug may be first targeted treatment for serious kidney disease

Treatment with rheumatoid arthritis drug saved transplanted kidney in four patients, achieved remission in a fifth

2013-11-09
(Press-News.org) Contact information: Mike Morrison
mdmorrison@partners.org
617-724-6425
Massachusetts General Hospital
Repurposed drug may be first targeted treatment for serious kidney disease Treatment with rheumatoid arthritis drug saved transplanted kidney in four patients, achieved remission in a fifth A drug approved for the treatment of rheumatoid arthritis may also turn out to be the first targeted therapy for one of the most common forms of kidney disease, a condition that almost inevitably leads to kidney failure. A team led by Massachusetts General Hospital (MGH) researchers is reporting that treatment with abatacept (Orencia) appeared to halt the course of focal segmental glomerulosclerosis (FSGS) in five patients, preventing four from losing transplanted kidneys and achieving disease remission in the fifth. The report is being issued online in the New England Journal of Medicine to coincide with a presentation at the American Society for Nephrology annual meeting.

"We identified abatacept as the first personalized, targeted treatment for kidney disease and specifically for FSGS, a devastating and largely untreatable disease," says Peter Mundel, MD, of the Division of Nephrology in the MGH Department of Medicine, senior author of the NEJM paper. "We also identified a biomarker that helps us discern which patients are most likely to benefit from therapy with abatacept."

FSGS is characterized by the formation of scar tissue in the glomeruli, the kidney's essential filtering units. Some forms of FSGS are inherited and some have no known cause, but the vast majority of cases develop in individuals with hypertension, obesity or diabetes. Although the underlying mechanism is unclear, FSGS disrupts the function of podocytes, cells within the glomeruli that are crucial to kidney function. While treatment with steroids and some immunosuppressive drugs helps some patients, the drugs' side effects make long-term use problematic.

Previous research by Mundel's team found that the expression on podocytes of an immune molecule called B7-1 signaled the breakdown of the kidney's filtering function, leading to protein leakage into the urine (proteinuria) and ultimate kidney failure. Currently approved for the treatment of rheumatoid arthritis and being studied for other conditions, abatacept inhibits the activity of B7-1, a molecule that is not expressed in healthy podocytes. After in vitro tests indicated that abatacept blocked the primary pathogenic effect of B7-1 expression in podocytes, the team tested treatment with the drug in five FSGS patients – four with recurrent disease affecting a transplanted kidney and one with treatment-resistant disease who was at high risk for kidney failure.

In all five patients, abatacept treatment induced remission of FSGS-caused proteinuria. Two of those with recurrent disease have remained in remission with a single dose of abatacept for three and four years. The other two required a second dose when proteinuria reappeared a few weeks later and have been in remission for 10 and 12 months respectively. The patient with high-risk, treatment-resistant disease, who is being treated at MGH, went into remission for the first time in more than a year, continues in remission a year later and has resumed a normal lifestyle. While she continues to receive monthly doses of abatacept, she no longer needs the high-dose steroids and immunosuppressive drugs she had been dependent on, some of which actually increase the risk for kidney failure.

An associate professor of Medicine at Harvard Medical School, Mundel explains that, while a large-scale clinical trial is needed, he and his colleagues are hopeful that abatacept will prove an effective treatment for kidney disease characterized by B7-1 expression on podocytes. "We have a decade of good experience with the use of abatacept for rheumatoid arthritis, so we have every reason to believe that it will be an excellent long-term option for the treatment of all B7-1-positive diseases, including FSGS and perhaps diabetic kidney disease."

INFORMATION:

Chih-Chuan Yu, MSc, of the MGH Nephrology Division is lead author of the NEJM report. Additional co-authors include Anna Greka, MD, an MGH nephrologist and assistant professor of Medicine at Harvard Medical School, and George Burke, MD, a transplant surgeon at the University of Miami in Florida. Support for the study includes grants from the National Institutes of Health, the Boston Area Diabetes Endocrinology Research Center and the American Society for Nephrology.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $775 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.

END



ELSE PRESS RELEASES FROM THIS DATE:

Universals of conversation

2013-11-09
Universals of conversation Max Planck researchers found that words that signal problems with understanding are similar across languages A word like 'Huh?' —used when one has not caught what someone just said—appears to be universal: it is found to have very ...

High-energy physicists predict new family of four-quark objects

2013-11-09
High-energy physicists predict new family of four-quark objects New charged charmonium-like states observed at BESIII An international team of high-energy physicists says the discovery of an electrically charged subatomic particle called Zc(4020) is ...

NASA's TRMM satellite sees Super-typhoon Haiyan strike Philippines

2013-11-09
NASA's TRMM satellite sees Super-typhoon Haiyan strike Philippines VIDEO: NASA's TRMM satellite data on Nov. 8 at 00:19 UTC showed Haiyan had a well-defined eye surrounded ...

Snap to attention: Polymers that react and move to light

2013-11-09
Snap to attention: Polymers that react and move to light PITTSBURGH—Microvehicles and other devices that can change shape or move with no power source other than a beam of light may be possible through research led by the University of Pittsburgh. The researchers are ...

New therapeutic target identified for ALS and frontotemporal degeneration

2013-11-09
New therapeutic target identified for ALS and frontotemporal degeneration A team of scientists led by researchers from the University of California, San Diego School of Medicine and Ludwig Institute for Cancer Research have identified a novel therapeutic approach ...

Montana State team overcomes challenges, proves that microbes swim to hydrogen gas

2013-11-09
Montana State team overcomes challenges, proves that microbes swim to hydrogen gas BOZEMAN, Mont. – Scientists have long believed that microorganisms that produce methane swim toward the hydrogen gas they need to stay alive, but it has been too hard to prove in ...

Sun unleashes another X-class flare

2013-11-09
Sun unleashes another X-class flare The sun emitted its sixth significant flare since Oct. 23, 2013, peaking at 11:26 p.m. EST on Nov. 7, 2013. Solar flares are powerful bursts of radiation. Harmful radiation from a flare cannot pass through Earth's ...

Hubble catches stellar explosions in NGC 6984

2013-11-09
Hubble catches stellar explosions in NGC 6984 Supernovae are intensely bright objects. They are formed when a star reaches the end of its life with a dramatic explosion, expelling most of its material out into space. The subject of this new Hubble ...

JCI early table of contents for Nov. 8, 2013

2013-11-08
JCI early table of contents for Nov. 8, 2013 Ion channel inhibition limits injury-induced loss of kidney filtration The kidney is responsible for retaining essential proteins and removing waste products from the blood stream. Injury to the kidney results ...

Ion channel inhibition limits injury-induced loss of kidney filtration

2013-11-08
Ion channel inhibition limits injury-induced loss of kidney filtration The kidney is responsible for retaining essential proteins and removing waste products from the blood stream. Injury to the kidney results in loss of kidney filter function, which ...

LAST 30 PRESS RELEASES:

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles

Defensive firearm use is far less common than exposure to gun violence

Lifetime and past-year defensive gun use

Lifetime health effects and cost-effectiveness of tirzepatide and semaglutide in US adults

[Press-News.org] Repurposed drug may be first targeted treatment for serious kidney disease
Treatment with rheumatoid arthritis drug saved transplanted kidney in four patients, achieved remission in a fifth